Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China
· Delayed Price · Currency is CNY 57.93
+1.40 (2.48%)
Mar 10, 2026, 11:44 AM CST
SHE:300347 Revenue
Hangzhou Tigermed Consulting had revenue of 1.78B CNY in the quarter ending September 30, 2025, with 3.86% growth. This brings the company's revenue in the last twelve months to 6.56B, down -3.53% year-over-year. In the year 2024, Hangzhou Tigermed Consulting had annual revenue of 6.60B, down -10.58%.
Revenue (ttm)
6.56B
Revenue Growth
-3.53%
P/S Ratio
7.01
Revenue / Employee
644.22K
Employees
10,251
Market Cap
45.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.60B | -780.92M | -10.58% |
| Dec 31, 2023 | 7.38B | 298.57M | 4.21% |
| Jan 1, 2023 | 7.09B | 1.87B | 35.91% |
| Jan 1, 2022 | 5.21B | 2.02B | 63.32% |
| Dec 31, 2020 | 3.19B | 388.97M | 13.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 1.67B |
| BGI Genomics | 3.71B |
| Guangzhou Kingmed Diagnostics Group | 6.11B |
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| WuXi AppTec | 43.88B |
| Amoy Diagnostics | 1.13B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |